Explore

Trendline Trendline
Global Rare Disease Genetic Testing Market Projected to Reach $5.72 Billion by 2035

Global Rare Disease Genetic Testing Market Projected to Reach $5.72 Billion by 2035

Global Rare Disease Genetic Testing Market Projected to Reach $5.72 Billion by 2035
Trendline Trendline
GRAIL's Galleri Test Shows Promise in Early Cancer Detection

GRAIL's Galleri Test Shows Promise in Early Cancer Detection

GRAIL's Galleri Test Shows Promise in Early Cancer Detection
Trendline Trendline
Prometheus Federal Services Seeks Lead Pharmacogenomics for Precision Medicine Initiative

Prometheus Federal Services Seeks Lead Pharmacogenomics for Precision Medicine Initiative

Prometheus Federal Services Seeks Lead Pharmacogenomics for Precision Medicine Initiative
Trendline Trendline
Geron Corporation Reports Q2 2026 Earnings with Strong RYTELO Sales Growth

Geron Corporation Reports Q2 2026 Earnings with Strong RYTELO Sales Growth

Geron Corporation Reports Q2 2026 Earnings with Strong RYTELO Sales Growth
Trendline Trendline
Hone Health and Midi Offer Distinct Approaches to Menopause and Longevity Care

Hone Health and Midi Offer Distinct Approaches to Menopause and Longevity Care

Hone Health and Midi Offer Distinct Approaches to Menopause and Longevity Care
Trendline Trendline
GRAIL Reports Financial Growth and Advances in Cancer Detection Technology

GRAIL Reports Financial Growth and Advances in Cancer Detection Technology

GRAIL Reports Financial Growth and Advances in Cancer Detection Technology
Trendline Trendline
SOPHiA GENETICS Reports Strong U.S. Market Growth in Q2 2026

SOPHiA GENETICS Reports Strong U.S. Market Growth in Q2 2026

SOPHiA GENETICS Reports Strong U.S. Market Growth in Q2 2026
Trendline Trendline
SOPHiA GENETICS Reports Strong Q2 2026 Financial Results

SOPHiA GENETICS Reports Strong Q2 2026 Financial Results

SOPHiA GENETICS Reports Strong Q2 2026 Financial Results
Trendline Trendline
CND Life Sciences Secures Financing to Expand Syn-One Test Platform for Neurodegenerative Diagnostics

CND Life Sciences Secures Financing to Expand Syn-One Test Platform for Neurodegenerative Diagnostics

CND Life Sciences Secures Financing to Expand Syn-One Test Platform for Neurodegenerative Diagnostics
Trendline Trendline
Personalis Reports Significant Growth in Q2 2026, Expands Medicare Coverage

Personalis Reports Significant Growth in Q2 2026, Expands Medicare Coverage

Personalis Reports Significant Growth in Q2 2026, Expands Medicare Coverage
Trendline Trendline
AI Medical Tools Surpass Doctors in Clinical Studies, Raising Ethical and Practical Concerns

AI Medical Tools Surpass Doctors in Clinical Studies, Raising Ethical and Practical Concerns

AI Medical Tools Surpass Doctors in Clinical Studies, Raising Ethical and Practical Concerns
Trendline Trendline
Pathos AI Expands Cancer Drug Pipeline with Deals from Alphamab and AstraZeneca

Pathos AI Expands Cancer Drug Pipeline with Deals from Alphamab and AstraZeneca

Pathos AI Expands Cancer Drug Pipeline with Deals from Alphamab and AstraZeneca